Zimmer Biomet Holdings, Inc. (BVMF:Z1BH34)

Market Cap	83.16B -22.1%
Revenue (ttm)	43.87B +9.2%
Net Income	3.97B -16.7%
EPS	20.12 -14.4%
Shares Out	n/a
PE Ratio	20.94
Forward PE	10.07
Dividend	0.80 (0.66%)
Ex-Dividend Date	Mar 30, 2026

Volume	1
Average Volume	51
Open	119.88
Previous Close	118.20
Day's Range	119.88 - 119.88
52-Week Range	115.00 - 132.04
Beta	0.47
RSI	37.56
Earnings Date	Apr 28, 2026

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well a...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1927
• Employees: 17,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: Z1BH34

Financial Performance

In 2025, Zimmer Biomet Holdings's revenue was $8.23 billion, an increase of 7.20% compared to the previous year's $7.68 billion. Earnings were $705.10 million, a decrease of -21.98%.

Financial numbers in USD